Conference abstract · 7 Mar 2016
Conference abstractPublished 2019
Nanovaccines for infectious diseases delivered via microneedle patches
Mercer University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The D’Souza Vaccine Nanotechnology Laboratory at Mercer’s College of Pharmacy has been working on the design and delivery of microparticulate vaccines for infectious diseases. This presentation will highlight the triumphs and tribulations of this rather innovative, in-expensive and painless method of vaccine delivery using microneedle technology. Our patented technology is rather broad based and can be used to administer multiple vaccines in a single microneedle vaccine patch applied to the skin much like a “band-aid-patch” We have been working on particulate vaccines for several infectious diseases such as a) universal influenza, b) HPV, c) RSV, d) meningitis, e) gonorrhea, and f) measles vaccines designed for delivery via microneedles. In this presentation, the results of these vaccine prototypes will be discussed. The vaccine antigen was formulated in bio-degradable and bio-compatible matrices to prepare nanoparticles or microparticles using a spray dryer. These nano-vaccine particles were administered using micro-needles via the transdermal route. Serum samples were obtained at regular intervals in-order to determine the antigen specific antibody responses (such as IgG, Igg1to assess the systemic immunity. Animals were challenges with live virus/bacteria to determine the level of protective immunity developed after vaccination. Further, we examined the expression of co-stimulatory molecules that impact antigen presentation in an in-vitro system using human macrophages pulsed with the antigen. In-order to determine the correlates of protection by the vaccine in-vivo, the total IgG and its subtypes IgG2a and IgG2b were measured after immunizing mice. The up regulation of other co-stimulatory molecules such as CD-40, CD-80 and CD-86 were also determined. In conclusion, the novel nano-vaccines are robustly taken up by antigen presenting cells and up-regulate co-stimulatory molecules that enhance antigen presentation, which is a pre-requisite for inducing adaptive immunity.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Aug 2016
Microneedle based transdermal vaccines for infectious diseases and cancer- Are we there yet?
Conference abstract · 2017
Transcutaneous immunization via rapidly dissolvable microneedles protects against hand-foot-and-mouth disease caused by Enterovirus 71
Research article · 14 Jun 2022
Fabrication and Characterization of Thiolated Chitosan Microneedle Patch of Azathioprine for Transdermal Drug Delivery
Conference abstract · 2019
Efficient hPTH delivery by poly vinyl pyrrolidone containing dissolvable microneedle patches
More from this journal
The newest in Journal of Vaccines & Clinical Trials.
Commentary · 28 Dec 2023
Cholera: A Historical Review, Epidemiology and Management
Commentary · 28 Dec 2023
Epidemiology and Global Impact of Dengue: Clinical Presentation and Disease Progression
Commentary · 28 Dec 2023
An Overview on Infectious Diseases: Its Global Impact and Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Clinical Trials
- SubjectPharmaceutical Sciences
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Martin D’Souza”

